FDA warns kratom sellers to stop making unproven claims about chronic pain, opioid addiction benefits

kratomplantdrugeffects
Image: Rattiya Thongdumhyu/Shutterstock

The Food and Drug Administration is still pressing down hard on kratom—the plant treatment that adherents say has helped them manage their opioid addiction or chronic pain. [June 25] the agency announced it was sending warning letters to two online marketers and distributors, accusing them of illegally selling kratom products with false or unproven claims about their health benefits.

These claims, detailed by the FDA in its warning letters to the two firms, include that kratom can help with opioid addiction or pain relief, but also go as far as to suggest that it can treat arthritis, insomnia, and even cancer.

ADVERTISEMENT

“Despite our warnings, companies continue to sell this dangerous product and make deceptive medical claims that are not backed by science or any reliable scientific evidence,” Ned Sharpless, the current acting FDA chief, said in a statement. “As we work to combat the opioid crisis, we cannot allow unscrupulous vendors to take advantage of consumers by selling products with unsubstantiated claims that they can treat opioid addiction or alleviate other medical conditions.”

Read full, original post: FDA Is Going After Kratom, Warning Companies to Stop Selling It for Opioid Addiction and Cancer

Related article:  Humans ‘are not so special after all’: Neanderthals also knew how to start fires, evidence suggests
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend